TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 101 filers reported holding TURNING POINT THERAPEUTICS I in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $686,000 | -35.0% | 7,248 | -16.4% | 0.05% | -37.7% |
Q4 2020 | $1,056,000 | +11.5% | 8,666 | -20.0% | 0.08% | -16.3% |
Q3 2020 | $947,000 | -14.5% | 10,839 | -36.8% | 0.09% | -7.1% |
Q2 2020 | $1,108,000 | +86.5% | 17,147 | +29.0% | 0.10% | +141.5% |
Q1 2020 | $594,000 | -51.8% | 13,294 | -32.8% | 0.04% | -28.1% |
Q4 2019 | $1,232,000 | +211.9% | 19,771 | +88.3% | 0.06% | +200.0% |
Q3 2019 | $395,000 | – | 10,498 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Cormorant Asset Management, LP | 2,392,297 | $291,501,000 | 6.94% |
Burrage Capital Management LLC | 72,484 | $8,832,000 | 6.73% |
MPM BioImpact LLC | 617,372 | $75,226,000 | 6.50% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 113,541 | $13,816,000 | 3.77% |
Orbimed Advisors | 2,745,327 | $334,518,000 | 2.93% |
SECTORAL ASSET MANAGEMENT INC | 257,379 | $31,362,000 | 2.21% |
Parkman Healthcare Partners LLC | 59,377 | $7,235,000 | 1.85% |
Nicholas Investment Partners, LP | 183,676 | $22,381,000 | 1.73% |
EMERALD ADVISERS, LLC | 357,038 | $43,505,000 | 1.44% |
EMERALD MUTUAL FUND ADVISERS TRUST | 336,173 | $40,963,000 | 1.42% |